WormMine: RNAi WBRNAi00071565

• WormBase ID: WBRNAi00071565
• Genotype: bIs1(vit-2::GFP); rrf-3(pk1426)
• Phenotype Remark: RNAi treatment resulted in an abnormal accumulation of YP170-GFP in the body cavity.
• Remark: Primary screen. L4 larval stage was applied to induced RNAi cultures.

1 Organism

• Name: Caenorhabditis elegans
• Taxon Id: 6239

1 Data Sets

• WormBaseAcedbConverter

3 Inhibits Gene

WormBase Gene ID	Gene Name	Sequence Name	Organism
WBGene00000063	act-1	T04C12.6	Caenorhabditis elegans
WBGene00000064	act-2	T04C12.5	Caenorhabditis elegans
WBGene00000065	act-3	T04C12.4	Caenorhabditis elegans

3 Inhibits Predicted Gene

WormMine ID	Sequence Name	Length (nt)	Chromosome Location
CDS:T04C12.6	T04C12.6	1131	V: 11081073-11081262
CDS:T04C12.4	T04C12.4	1131	V: 11072012-11072171
CDS:T04C12.5	T04C12.5	1131	V: 11076900-11077059

1 Laboratories

Primary Identifier
RT

2 Phenotype

Identifier	Name	Description
WBPhenotype:0000961	pattern of transgene expression variant	Any variation in the cellular or subcellular pattern of expression of a gene product produced by exogenous DNA that has been introduced into the organism compared to its expression in control animals.
WBPhenotype:0001425	receptor mediated endocytosis defective	Animals exhibit defects in the cell-mediated uptake of external materials via receptor activity. Receptor-mediated endocytosis ensures specificity of transport and generally occurs via clathrin-coated pits and vesicles. In C. elegans, this is often judged by the lack of yolk uptake in oocytes.

0 Phenotype _ Not _ Observed

1 Reference

First Author	Title	Year	Journal	Volume	Pages	PubMed ID
						WBPaper00030951

0 Strain